DEEP VENOUS THROMBOSIS
Clinical trials for DEEP VENOUS THROMBOSIS explained in plain language.
Never miss a new study
Get alerted when new DEEP VENOUS THROMBOSIS trials appear
Sign up with your email to follow new studies for DEEP VENOUS THROMBOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New blood thinner tested for cancer clot prevention, study halted early
Disease control TerminatedThis study tested a new blood thinner, abelacimab, against a standard one (dalteparin) in 417 adults with gastrointestinal or genitourinary cancers who also had blood clots. The goal was to see which drug better prevented new clots and caused less bleeding. The trial was terminat…
Matched conditions: DEEP VENOUS THROMBOSIS
Phase: PHASE3 • Sponsor: Anthos Therapeutics, Inc. • Aim: Disease control
Last updated May 22, 2026 13:52 UTC
-
New blood thinner tested for cancer patients at risk of clots
Disease control TerminatedThis study tested a new blood thinner called abelacimab against the standard drug apixaban in about 1,150 people with cancer who had a blood clot (VTE). The goal was to see which drug better prevents new clots and causes less bleeding. The trial was stopped early, so final result…
Matched conditions: DEEP VENOUS THROMBOSIS
Phase: PHASE3 • Sponsor: Anthos Therapeutics, Inc. • Aim: Disease control
Last updated May 20, 2026 11:57 UTC